Fritextsökning
Innehållstyper
-
Precision and accuracy in liquid handling
How to evaluate and optimize liquid handling performance
-
Rising interest in CRISPR treatments
Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
Don't miss ZEISS Quality Innovation Days
Digital event April 15-19, 2024.
-
The dock that “thinks” for itself
The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...
-
Pfizer’s Paxlovid is being tested against post-COVID in a major Swedish study
In a new study conducted at the Karolinska University Hospital, Pfizer’s COVID drug, Paxlovid, is now being tested in patients with post-COVID. The study is one...
-
Anna Törner: The minute between life and death
“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...
-
Learn from Speakers from Leading MedTech Companies
Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.
-
Final assembly inspection of medical plastics
Technical paper by ZEISS Medical Industry Solutions.
-
Ozempic may benefit hip replacement surgery
The high-profile drug for type 2 diabetes and weight loss may be beneficial in other areas. One such area is for patients undergoing hip replacement surgery, a ...
-
Fuskanklagat pharmabolag lägger ner alzheimerprojekt
Amerikanska Cassava Sciences avbryter utvecklingen av sin läkemedelskandidat inom Alzheimers sjukdom efter misslyckande i en fas III-studie
-
Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”
The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.
-
The first Lyme disease vaccine faces a delay
Pfizer and Valneva’s Lyme disease vaccine, which could be the first of its kind, is facing delays of about a year. The reason is problems at trial sites in the ...
-
Ranking: Top 10 highest-paid CEOs in pharma
It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the ...
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
-
How Volume EM Advances Life Science Research
Free webinar series.
-
The first drugs to slow down Alzheimer’s – but what does it mean for patients?
New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...
-
Lista: Årets mest framstående medicinska uppfinningar
Den subkutana formen av det svenskutvecklade alzheimerläkemedlet Leqembi lyfts fram när Time presenterar sin årliga lista över de bästa uppfinningarna 2025.
-
How to optimise your liquid handling results
In dispensing or pipetting applications in laboratory automation, it is important to obtain reliable results, which are analysed by calculating the accuracy and...
-
19 medicines in Sweden are under investigation in a major EMA inquiry
19 medicines marketed in Sweden are affected by an ongoing extensive European investigation into suspected fraud at an Indian contract research organisation. Am...
-
Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease
According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...
-
Advanced Microfluidics Flow Analysis Made Easy
Case study with ZEISS Airyscan.
-
Study: Vaccination linked to lower risk of post-COVID
The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.
-
Claims of life science companies fleeing abroad is a myth according to survey
The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.
BREAKING